Rectal Cancer
Conditions
Brief summary
Transanal total mesorectal excision (TaTME) is an alternative for mid-low rectal cancer. In China, this procedure has been performed in high-volume centers with structured training curriculums. This study aimed to evaluate the short-term outcomes during the initial implementation of the TaTME procedure in high-volume centers who followed structured training curriculums in China.
Interventions
Transanal Total Mesorectal Excision
Sponsors
Study design
Eligibility
Inclusion criteria
* Age between 18 and 75 years * American Society of Anesthesiologists (ASA) score I to III * A biopsy proven histological diagnosis of rectal carcinoma * Undergoing transanal total mesorectal excision
Exclusion criteria
* Pregnant or lactating women * Synchronous rectal carcinoma * History of colorectal cancer or other malignant tumors * Clinical evidence of metastasis * Emergency procedure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| incidence of anastomotic leakage | thirty days after surgery | according to the International Rectal Cancer Study Group |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| incidence of Defecation disorders | 6 months after surgery | A Wexner score \>10 indicated the existence of defecation dysfunction |
| incidence of positive distal resection margin | 30 days after surgery | A positive distal resection margin (DRM) was diagnosed with the presence of tumor cells within 1mm from the DRM |
| incidence of positivecircumferential resection margin | 30 days after surgery | The positive circumferential resection margin (CRM) was defined as the presence of tumor cells within 1 mm from the CRM |
Countries
China